Idiopathic intracranial hypertension following kidney transplantation: a case report and review of the literature.
A pediatric kidney transplant recipient receiving tacrolimus for immunosuppression experienced symptoms consistent with idiopathic intracranial hypertension. The diagnosis of idiopathic intracranial hypertension and possible secondary causes of intracranial hypertension are reviewed in association with the patient's clinical course. Treatment options for the reversal of intracranial hypertension are summarized. Because of the complexity of associated conditions in kidney transplant recipients, symptoms of persistent headaches, visual changes and nausea and vomiting should be promptly investigated by fundoscopic examination in the setting of immunosuppression therapy to prevent vision loss.
Chamberlain
Christine E
CE
Pharmacy Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA. cchamberla@nih.gov
Fitzgibbon
Edmond
E
Wassermann
Eric M
EM
Butman
John A
JA
Kettl
David
D
Hale
Doug
D
Kirk
Allan D
AD
Mannon
Roslyn B
RB
D002648:Child; D005260:Female; D006801:Humans; D019586:Intracranial Hypertension / Q000139:chemically induced*; D016030:Kidney Transplantation; D018810:Magnetic Resonance Angiography; D050177:Overweight; D016559:Tacrolimus / Q000009:adverse effects*
D016559:Tacrolimus